Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EPS (Weighted Average and Diluted) (2023 - 2025)

Incannex Healthcare's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.02 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 93.94% year-over-year to -$0.02; the TTM value through Dec 2025 reached -$0.74, up 45.59%, while the annual FY2025 figure was -$1.35, 17.39% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.02 at Incannex Healthcare, roughly flat from -$0.02 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.02 in Q3 2025 and bottomed at -$0.51 in Q2 2025.
  • The 3-year median for EPS (Weighted Average and Diluted) is -$0.31 (2023), against an average of -$0.25.
  • The largest annual shift saw EPS (Weighted Average and Diluted) plummeted 262.5% in 2024 before it skyrocketed 93.94% in 2025.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.33 in 2023, then changed by 0.0% to -$0.33 in 2024, then surged by 93.94% to -$0.02 in 2025.
  • Per Business Quant, the three most recent readings for IXHL's EPS (Weighted Average and Diluted) are -$0.02 (Q4 2025), -$0.02 (Q3 2025), and -$0.51 (Q2 2025).